CGEN:NASDAQ
Compugen Ltd
$2.49
arrow_upward
+1.22%(+0.030) 1D
$2.48
arrow_downward
-0.40% (-0.0100)bedtimeAfter hours
Closed: Sep 18, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CGEN...
Open
$2.47
High
$2.49
Low
$2.45
Mkt. cap
235.87M
Avg. vol.
283.52K
Volume
128.00K
P/E ratio
6.86
52-wk high
$3.24
52-wk low
$1.30
EPS
$0.36
Beta
2.78
Shares outstanding
94.73M
No. of employees
75
Open
$2.47
High
$2.49
Low
$2.45
Mkt. cap
235.87M
Avg. vol.
283.52K
Volume
128.00K
P/E ratio
6.86
52-wk high
$3.24
52-wk low
$1.30
EPS
$0.36
Beta
2.78
Shares outstanding
94.73M
No. of employees
75
News stories
From web sources and news partners
CarePlus VietNam
·
2 weeks ago
Compugen (CGEN) Holds Near $2.62 as Shares Navigate Tight $2.49–$2.75 Range - Bullish Pattern Stocks
CarePlus VietNam
·
1 month ago
Compugen Ltd. (CGEN) Slides 3.6% as Biotech Stock Approaches Key $2.29 Support - Hot Stock Picks
CarePlus VietNam
·
1 month ago
Compugen (CGEN) Slips 1.8% to $2.46 as Shares Hover Near Key Support - Value Stock Ideas
CarePlus VietNam
·
1 month ago
Compugen (CGEN) Gains 4.17% to $2.50 as Immuno-Oncology Stock Shows Resilience - Range Breakout
Profile
Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big companies such as Novartis AG, Abbot Laboratories and Pfizer Inc. Subsequently, Compugen made a decision to become a drug development company with its own internal pipeline, and in 2010, decided to a focus on oncology and immunology. OncoMed Pharmaceuticals and Five Prime Therapeutics are among Compugen's competitors. Wikipedia
About Compugen Ltd